I see @flock_io has also joined the Wall Street DAT (Digital Asset Treasury) narrative. Interestingly, FLock's collaboration with CIMG Inc. is quite different from the common market approach of buying ETH and BTC as reserve assets to drive up stock prices. Let's explain in detail: Specifically, FLock and CIMG Inc. have adopted a deeply integrated business collaboration model. CIMG will purchase $FLOCK tokens as reserve assets. The two parties will also jointly develop an AI health monitoring and intelligent recommendation product called LifeNode, for which FLock will provide AI privacy computing and federated learning technical services. 1) The DAT model, currently all the rage on Wall Street, is essentially a rehash of the Crypto (3.3) model: buy coins → stock price rises → issue bonds → buy more coins. Its positive flywheel operation relies on a unilaterally positive market, somewhat resembling a "Ponzi" approach. This is part of the first wave of speculative DATs. Wall Street listed companies leveraged crypto to hype their stock prices, and the crypto market leveraged Wall Street's Fomo to attract incremental external capital to drive market growth. The FLock and CIMG partnership model employs a deep "business + token" integration. On the one hand, due to the token acquisition, the value of FLock's tokens is substantially linked to the listed company's core business. On the other hand, FLock's AI technology supply services will directly impact CIMG's strategy and market performance. In other words, the partnership between the two companies goes beyond simple speculation, but rather creates business synergy and value linkage. 2) To understand this in depth, we must delve into CIMG Inc., a listed company. This company is quite interesting. While ostensibly a coffee company, it has transformed itself into a digital health group powered by a dual engine of "technology + marketing" through a series of acquisitions (Xilin Online's AI-powered product selection and Holmau Culture's "industry + AI + capital"). This collaboration with FLock is a direct jump from AI applications in marketing to AI innovation on the product side. With the launch of LifeNode, CIMG has truly transitioned from an "AI-using company" to a "company that makes AI products." Crucially, FLock's federated learning and privacy-preserving computing technologies address the core pain point of health data applications: how to achieve AI-powered personalized services while protecting user privacy. 3) In fact, if the FLock and CIMG partnership succeeds, it could usher in the era of DATs 2.0—production-oriented DATs. This model benefits both parties: FLock, with stable B-side customers and financial support, can focus on technology research and development; CIMG, it gains advanced AI capabilities while also benefiting from the crypto industry's growth through its token reserves. Critically, LifeNode's application implementation will form the foundation of the partnership, and subsequent user growth, technological iteration, and commercialization progress will all feed back into the benefits of the partnership.